Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.97614 | 66 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.83506 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.26488 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.76356 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.73545 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.0971 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.07609 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.85896 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.48974 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.21674 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.87101 | 65 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.7249 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.92094 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.82097 | 64 |